Advantages |
May enable targeted delivery of a high concentration of antimicrobial to site of infection |
Higher likelihood of adherence to treatment (e.g., in children) |
Less potential for systemic side effects and toxicity |
May avoid need for systemic antimicrobials |
Ensures that site of infection is regularly inspected |
Topical application allows use and development of agents that may not be able to be used systemically (e.g., neomycin or bacitracin) |
Topical route of administration may be easier for patients and caregivers |
Disadvantages |
Limited evidence base for clinical effectiveness |
Many agents associated with local allergy |
Limited understanding of potentially deleterious effects on skin microbiota |
Minimal depth of penetration, limiting use on intact skin |
Unquantified effects on wound healing process |
Widespread and unrestricted use is likely to select for bacterial resistance (e.g., fusidic acid and Staphylococcus aureus) |
Potential for storage in patient homes, with possibility of recurrent use and contamination |
Often combined with topical steroid therapy, meaning that primary prescribing indication may be for inflammation rather than infection |
Potential perception by both patients and prescribers as more “benign” than systemic antimicrobials |
May be difficult for some patients to apply to larger surface areas or skin folds |